Combination pharmacological therapies for the management of benign prostatic hyperplasia.
about
The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis.Effect of Longbishu capsule () plus doxazosin on benign prostatic hyperplasia: a randomized controlled trial.Long-Term (24 Months) Carcinogenicity Study of D-004, a Lipid Extract From Roystonea regia Fruits, in Sprague Dawley Rats.Efficacy and safety of orally disintegrating tamsulosin tablets in Taiwanese patients with benign prostatic hyperplasia
P2860
Combination pharmacological therapies for the management of benign prostatic hyperplasia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Combination pharmacological therapies for the management of benign prostatic hyperplasia.
@en
Combination pharmacological therapies for the management of benign prostatic hyperplasia.
@nl
type
label
Combination pharmacological therapies for the management of benign prostatic hyperplasia.
@en
Combination pharmacological therapies for the management of benign prostatic hyperplasia.
@nl
prefLabel
Combination pharmacological therapies for the management of benign prostatic hyperplasia.
@en
Combination pharmacological therapies for the management of benign prostatic hyperplasia.
@nl
P2860
P1433
P1476
Combination pharmacological therapies for the management of benign prostatic hyperplasia.
@en
P2093
J Kellogg Parsons
Seth A Cohen
P2860
P304
P356
10.2165/11598600-000000000-00000
P577
2012-04-01T00:00:00Z
P5875
P6179
1009240249